每經(jing)AI快訊，國邦(bang)醫藥（SH 605507，收盤價(jia)：17.91元(yuan)）12月(yue)(yue)24日(ri)(ri)晚(wan)間發布公(gong)告稱，截至(zhi)本(ben)(ben)(ben)(ben)公(gong)告披(pi)露(lu)日(ri)(ri)，股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)東上(shang)饒市浙民投(tou)(tou)恒華(hua)創業(ye)投(tou)(tou)資(zi)合(he)伙企業(ye)（有(you)限(xian)(xian)合(he)伙）、浙江絲路(lu)產業(ye)投(tou)(tou)資(zi)基(ji)金(jin)(jin)合(he)伙企業(ye)（有(you)限(xian)(xian)合(he)伙）分別持(chi)(chi)(chi)有(you)國邦(bang)醫藥集(ji)團股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)有(you)限(xian)(xian)公(gong)司(si)(si)(si)(si)(si)無限(xian)(xian)售(shou)流通(tong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)約2078萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)、約1573萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)3.72%、2.82%。浙民投(tou)(tou)恒華(hua)、絲路(lu)基(ji)金(jin)(jin)為一致行(xing)動(dong)人，合(he)計(ji)(ji)持(chi)(chi)(chi)有(you)公(gong)司(si)(si)(si)(si)(si)無限(xian)(xian)售(shou)流通(tong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)約3651萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)，占(zhan)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)6.53%。相關(guan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)已于2023年2月(yue)(yue)2日(ri)(ri)解除(chu)限(xian)(xian)售(shou)并(bing)上(shang)市流通(tong)。股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)東浙民投(tou)(tou)恒華(hua)、絲路(lu)基(ji)金(jin)(jin)因自身資(zi)金(jin)(jin)需(xu)求，計(ji)(ji)劃通(tong)過(guo)(guo)(guo)集(ji)中競(jing)價(jia)及大宗(zong)交易(yi)方式減(jian)(jian)(jian)持(chi)(chi)(chi)其持(chi)(chi)(chi)有(you)的(de)(de)(de)公(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)合(he)計(ji)(ji)不(bu)超(chao)過(guo)(guo)(guo)約1676萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)，減(jian)(jian)(jian)持(chi)(chi)(chi)比例(li)不(bu)超(chao)過(guo)(guo)(guo)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)3%。其中：擬通(tong)過(guo)(guo)(guo)集(ji)中競(jing)價(jia)方式進行(xing)減(jian)(jian)(jian)持(chi)(chi)(chi)的(de)(de)(de)，將于本(ben)(ben)(ben)(ben)公(gong)告披(pi)露(lu)之日(ri)(ri)起(qi)15個交易(yi)日(ri)(ri)后(hou)的(de)(de)(de)3個月(yue)(yue)內(nei)減(jian)(jian)(jian)持(chi)(chi)(chi)公(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)不(bu)超(chao)過(guo)(guo)(guo)約559萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)，即減(jian)(jian)(jian)持(chi)(chi)(chi)不(bu)超(chao)過(guo)(guo)(guo)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)1%，且在任(ren)意(yi)連(lian)續90日(ri)(ri)內(nei)，合(he)計(ji)(ji)減(jian)(jian)(jian)持(chi)(chi)(chi)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)總(zong)數不(bu)超(chao)過(guo)(guo)(guo)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)1%；擬通(tong)過(guo)(guo)(guo)大宗(zong)交易(yi)方式進行(xing)減(jian)(jian)(jian)持(chi)(chi)(chi)的(de)(de)(de)，將于本(ben)(ben)(ben)(ben)公(gong)告披(pi)露(lu)之日(ri)(ri)起(qi)3個交易(yi)日(ri)(ri)后(hou)的(de)(de)(de)3個月(yue)(yue)內(nei)減(jian)(jian)(jian)持(chi)(chi)(chi)公(gong)司(si)(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)不(bu)超(chao)過(guo)(guo)(guo)約1118萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)，即減(jian)(jian)(jian)持(chi)(chi)(chi)不(bu)超(chao)過(guo)(guo)(guo)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)2%，且在任(ren)意(yi)連(lian)續90日(ri)(ri)內(nei)，合(he)計(ji)(ji)減(jian)(jian)(jian)持(chi)(chi)(chi)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)總(zong)數不(bu)超(chao)過(guo)(guo)(guo)公(gong)司(si)(si)(si)(si)(si)總(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)的(de)(de)(de)2%。

2022年1至12月份，國邦醫藥的營業收入構成為：醫藥板(ban)塊(kuai)占比(bi)63.17%，動物保健(jian)品板(ban)塊(kuai)占比(bi)36.52%。

國邦醫藥的(de)董(dong)事長是邱(qiu)家軍，男，58歲，學(xue)歷背景為博士(shi)；總裁是廖仕學(xue)，男，48歲，學(xue)歷背景為碩士(shi)。

截(jie)至發稿，國(guo)邦(bang)醫藥市值(zhi)為100億元(yuan)。

道達(da)號（daoda1997）“個股趨勢”提醒：
1. 國邦醫藥近30日內北向資金持股量減少43.20萬股，占流通股比例減少0.14%；
2. 近30日內無機構對國邦醫藥進行調研；
3. 國邦醫藥上次發布減持公告是2023年10月25日，第二個交易日下跌0.47%，國邦醫藥近一年共發布7次減持類公告。
更多個股(gu)趨勢信息，請搜(sou)索微(wei)信公(gong)眾號“道達號”，回復“查詢”，領取免費(fei)查詢權限！

每經頭條（nbdtoutiao）——

(記者 王曉波)

免責聲明：本文內容與(yu)數據(ju)僅供(gong)參(can)考，不構成投(tou)資建議，使用前請核實。據(ju)此操作，風險(xian)自擔。